BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, ...

Becton, Dickinson and Company (BD) has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush prefilled flush syringes at its facility in Columbus, Nebraska, US. This ...

BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...

At MD&M West, he will present “ The Needle Boom: Scaling Overmolded Needle Manufacturing for the At Home Care Revolution ,” ...

New Manufacturing Lines Will Provide U.S. Government with Priority Access to Hundreds of Millions of Needles and Syringes; Bolster Supply Readiness FRANKLIN LAKES, N.J., Oct. 7, 2021 /PRNewswire/ -- ...

Medtech giant BD has announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, NE, facility. The investments ...

West has launched Synchrony S1, a prefillable syringe system to simplify biologic delivery and combination product needs.

FRANKLIN LAKES, N.J., Dec. 2, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 ...

FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...

THE Senate has urged the Federal Government to come forward with a policy that will ensure that all government funded hospitals in the country procure their syringes and needles from local ...